Abcam, ab168790, Anti-DLC1 antibody

Size: 50µg
Mouse Polyclonal DLC1 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human DLC1.
Key facts
Host species:Mouse,
Clonality:Polyclonal,
Isotype:IgG,
Carrier free:No,
Reacts with:Human,
Applications:WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:Recombinant Full Length Protein corresponding to Human DLC1.Q96QB1

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage duration-1-2 weeks, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
DLC1 also known as Deleted in Liver Cancer 1 is a tumor suppressor protein with a mass of approximately 123 kilodaltons. It functions mechanically as a Rho GTPase-activating protein (RhoGAP) regulating the activity of Rho family GTPases. DLC1 is expressed in various tissues with significant expression in the liver lung and kidney. The protein helps maintain cytoskeletal integrity and cell stability by modulating actin dynamics and cellular contractility.
Biological function summary
The protein DLC1 plays an important role in cell migration proliferation and adhesion. It often forms part of a multi-protein complex with tensin proteins which helps link it to the actin cytoskeleton. Through its GAP activity DLC1 negatively regulates RhoA a small GTPase. This regulation affects cell shape and movement by controlling focal adhesion turnover and stress fiber formation essential processes in maintaining normal cellular architecture.
Pathways
DLC1 impacts cellular signaling related to the cell cycle and apoptosis. It is heavily involved in the regulation of the Rho/Rac signaling pathway which is critical for actin cytoskeleton organization and cellular dynamics. DLC1 interacts with proteins such as RhoA and Cdc42 within these pathways facilitating signal transduction that affects cellular responses to external stimuli and internal checkpoints ensuring proper cell division and programmed cell death.
DLC1 is closely related to various cancers including liver and breast cancer. Its tumor suppressor function is often lost or reduced in these conditions leading to unchecked cellular proliferation and metastasis. In the context of liver cancer DLC1 interacts with proteins such as PTEN influencing tumor growth and progression. Aberrations in DLC1 expression or activity can also correlate with other disorders involving disrupted cell signaling and cytoskeletal abnormalities.